PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.\', \'Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.\', \'Center for Virology, Medical University of Vienna, Vienna, Austria.\', \'Department of Pathology, Medical University of Vienna, Vienna, Austria.\', \'Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.\', \'Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria daniel.aletaha@meduniwien.ac.at.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2021-220781
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 34285048
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all